Detalhe da pesquisa
1.
Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum.
J Virol
; 93(18)2019 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243134
2.
The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer.
Br J Cancer
; 121(8): 647-658, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31530903
3.
Oncolytic activity of the rhabdovirus VSV-GP against prostate cancer.
Int J Cancer
; 143(7): 1786-1796, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29696636
4.
Lassa-vesicular stomatitis chimeric virus safely destroys brain tumors.
J Virol
; 89(13): 6711-24, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25878115
5.
Vesicular stomatitis virus variants selectively infect and kill human melanomas but not normal melanocytes.
J Virol
; 87(12): 6644-59, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23552414
6.
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma.
J Immunother Cancer
; 12(4)2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38631706
7.
Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP.
Front Immunol
; 13: 1100730, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36741416
8.
Evaluating Antibody Pharmacokinetics as Prerequisite for Determining True Efficacy as Shown by Dual Targeting of PD-1 and CD96.
Biomedicines
; 10(9)2022 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36140247
9.
Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells.
J Virol
; 84(3): 1563-73, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19906910
10.
Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits.
Cancers (Basel)
; 13(14)2021 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34298601
11.
Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect.
Cancers (Basel)
; 13(23)2021 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34885215
12.
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity.
Nat Commun
; 12(1): 5195, 2021 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34465781
13.
SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic Target.
Cancers (Basel)
; 13(19)2021 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638429
14.
Peripheral immunization blocks lethal actions of vesicular stomatitis virus within the brain.
J Virol
; 83(22): 11540-9, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19726512
15.
Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue.
Methods Mol Biol
; 2058: 155-177, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31486037
16.
In Vivo Bioimaging for Monitoring Intratumoral Virus Activity.
Methods Mol Biol
; 2058: 237-248, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31486042
17.
Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series.
Front Oncol
; 10: 702, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32477944
18.
Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain.
J Neurosci
; 28(8): 1882-93, 2008 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18287505
19.
The Methyltransferase Region of Vesicular Stomatitis Virus L Polymerase Is a Target Site for Functional Intramolecular Insertion.
Viruses
; 11(11)2019 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31717818
20.
Sprouty2 enhances the tumorigenic potential of glioblastoma cells.
Neuro Oncol
; 20(8): 1044-1054, 2018 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29635363